Fourrts Global
SFA Login
Fourrts is a well-respected, quality focussed contract manufacturing facility for customers in the United Kingdom, Europe, Australia, Canada and other SRA countries.
Fourrts Plant II is a state-of-the-art US FDA / UK MHRA / EU GMP approved facility along with Desk-top approval from Health Canada and TGA Australia. We offer contract manufacturing services and formulation development.
Current Production capacity is 3.2 Billion Tablets and 350 Million Capsules and additionally planned to add 1 Billion Tabs by March 26. The site is equipped with 5 Granulation suites, 5 Compression lines, 4 Coating Sections and 8 Packaging lines (7 Blisters and 1 Bottle). The site is also capable of manufacturing Pellet based products as Granulation Suite 3 is equipped with both Top and Bottom Spray FBE.
Excellent in-house Research and Development Lab – a miniature production facility is supported by a dedicated team of scientists who are experienced in both product development and tech transfer.
Fourrts holds UK Market Authorization for Metformin F/c Tabs 500/850mg; Ibuprofen F/c Tabs 200/400/600mg; Paracetamol Tabs/Caps 500mg; Propranolol Tabs 10/40mg; Atenolol Tabs 25/50/100mg and Furosemide Tabs 20/40mg. Working extensively on pipeline of many products for Europe, USA and other markets.